Reuters - Western generic drugmakers need to adapt to cope with rapid changes in the pharmaceuticals market that are blurring the distinctions between innovator companies and makers of cheaper copycat products.

HealthDay - TUESDAY, Dec. 20 (HealthDay News) -- Edarbyclor (azilsartan medoxomil and chlorthalidone) has been approved by the U.S. Food and Drug Administration to treat high blood pressure in adults, maker Takeda Pharmaceutical Co. Ltd. said Tuesday in a news release.

AP - Three top European pharmaceutical companies announced on Tuesday disappointing news from clinical tests on drugs they had hoped would turn out to be big sellers.

ContributorNetwork - COMMENTARY | The Academy of Nutrition and Dietetics announced on Monday that it is urging the Centers for Medicare and Medicaid Services to make changes. The Academy believes that medical nutrition therapy must be expanded to include more conditions. The organization is once again highlighting an ongoing problem with Medicare's focus on acute illness and the inability to properly manage chronic conditions.

HealthDay - FRIDAY, Dec. 16 (HealthDay News) -- Draft recommendations meant to increase the number of women in clinical trials for medical devices were released Friday by the U.S. Food and Drug Administration.

HealthDay - WEDNESDAY, Dec. 14 (HealthDay News) -- Alcohol use by American teens has dropped to historic lows, but more of them are using marijuana and don't believe it's a dangerous drug, according to an annual national survey conducted by the U.S. National Institute on Drug Abuse and the University of Michigan.

HealthDay - WEDNESDAY, Dec. 14 (HealthDay News) -- Alcohol use by American teens has dropped to historic lows, but more of them are using marijuana and don't believe it's a dangerous drug, according to an annual national survey conducted by the U.S. National Institute on Drug Abuse and the University of Michigan.

HealthDay - TUESDAY, Dec. 13 (HealthDay News) -- Each year in the United States, one of every 150 two-year-olds visits an emergency room for treatment of an accidental medication overdose, a new government report shows.

HealthDay - TUESDAY, Dec. 13 (HealthDay News) -- Each year in the United States, one of every 150 two-year-olds visits an emergency room for treatment of an accidental medication overdose, a new government report shows.

Reuters - Pharmacy benefits manager Express Scripts Inc and its client WellPoint Inc said on Tuesday they are involved in a contract dispute and that they are trying to settle it through negotiation.

Reuters - Pharmacy benefits manager Express Scripts Inc and its client WellPoint Inc said on Tuesday they are involved in a contract dispute and that they are trying to settle it through negotiation.

Reuters - Health authorities are directing Medicare prescription drug plans to withhold payments for popular painkillers when they suspect patient abuse, part of a wider effort to combat fraud.

Reuters - Health authorities are directing Medicare prescription drug plans to withhold payments for popular painkillers when they suspect patient abuse, part of a wider effort to combat fraud.

Reuters - Spending by U.S. states on Medicaid, the healthcare program for the poor, soared last year and will likely continue growing despite measures to contain costs, according to a report released on Tuesday.

Reuters - Spending by U.S. states on Medicaid, the healthcare program for the poor, soared last year and will likely continue growing despite measures to contain costs, according to a report released on Tuesday.

Reuters - Takeda Pharmaceutical Co's Velcade reduced the risk of death by 31 percent when used in combination with standard medicines in previously untreated multiple myeloma patients, according to five-year follow-up data from a late stage clinical trial.

Reuters - Takeda Pharmaceutical Co's Velcade reduced the risk of death by 31 percent when used in combination with standard medicines in previously untreated multiple myeloma patients, according to five-year follow-up data from a late stage clinical trial.

Reuters - Up to a fifth of patients being treated for depression with some medications may do worse than those given a placebo, according to a U.S. study.

Reuters - Up to a fifth of patients being treated for depression with some medications may do worse than those given a placebo, according to a U.S. study.

HealthDay - WEDNESDAY, Dec. 7 (HealthDay News) -- In November, the U.S. Food and Drug Administration revoked its approval of the drug Avastin for the treatment of breast cancer. But, a new study suggests that the drug can boost the survival of women with a specific type of aggressive breast tumor when used in conjunction with two other medications.